Okajima K, Uchiba M, Murakami K, Okabe H, Takatsuki K
Department of Laboratory Medicine, Kumamoto University Medical School, Japan.
Am J Hematol. 1997 Mar;54(3):219-24. doi: 10.1002/(sici)1096-8652(199703)54:3<219::aid-ajh8>3.0.co;2-z.
The plasma level of soluble E-selectin (sE) reflects the activation of endothelial cells induced by cytokines such as tumor necrosis factor-alpha and interleukin-1 in vitro. These cytokines are important in the development of coagulation abnormalities in patients with sepsis. We compared the plasma levels of sE in patients with infections suspected of having disseminated intravascular coagulation (DIC) (n = 33) and in patients with underlying disorders other than infections, including solid tumors (n = 28), obstetric disorders (n = 13), hematologic malignancies (n = 13), and liver disease (n = 9), to clarify the involvement of cytokines in the development of coagulation abnormalities in patients with sepsis. Plasma levels of sE in patients with infection were significantly higher than in patients with the other underlying disorders. The plasma level of sE was also significantly higher in patients with infection with DIC (114.6 +/- 77.9 ng/ml, n = 21) than in patients with infection without DIC (54.5 +/- 53.1 ng/ml, n = 12, P < 0.02). There was no significant difference in sE level between patients with the other underlying disorders with and without DIC. The plasma level of sE was significantly correlated with the serum level of FDP(E) in patients with infection. The plasma level of sE was significantly higher in patients with infection with organ failure compared to patients without organ failure. There was no significant difference between patients with the other underlying disorders with and without organ failure. Plasma levels of tumor necrosis factor-alpha and interleukin-6 were detected in only 12.1% and 20.0% of patients with infections, respectively. These observations strongly suggest that plasma levels of sE reflect the activation of endothelial cells induced by cytokines, which may lead to DIC and organ failure in the presence of sepsis. Furthermore, determination of plasma level of sE may be useful for detecting the endothelial activation induced by cytokines in the pathologic conditions of sepsis, even when plasma levels of cytokines cannot be detected.
可溶性E选择素(sE)的血浆水平反映了体外肿瘤坏死因子-α和白细胞介素-1等细胞因子诱导的内皮细胞活化。这些细胞因子在脓毒症患者凝血异常的发生发展中起重要作用。我们比较了疑似发生弥散性血管内凝血(DIC)的感染患者(n = 33)以及患有包括实体瘤(n = 28)、产科疾病(n = 13)、血液系统恶性肿瘤(n = 13)和肝病(n = 9)等非感染性基础疾病的患者的sE血浆水平,以阐明细胞因子在脓毒症患者凝血异常发生发展中的作用。感染患者的sE血浆水平显著高于其他基础疾病患者。感染合并DIC患者的sE血浆水平(114.6±77.9 ng/ml,n = 21)也显著高于未合并DIC的感染患者(54.5±53.1 ng/ml,n = 12,P < 0.02)。其他基础疾病合并和未合并DIC的患者之间sE水平无显著差异。感染患者的sE血浆水平与FDP(E)血清水平显著相关。感染合并器官衰竭患者的sE血浆水平显著高于未合并器官衰竭的患者。其他基础疾病合并和未合并器官衰竭的患者之间无显著差异。仅分别在12.1%和20.0%的感染患者中检测到肿瘤坏死因子-α和白细胞介素-6的血浆水平。这些观察结果强烈表明,sE血浆水平反映了细胞因子诱导的内皮细胞活化,在脓毒症存在时可能导致DIC和器官衰竭。此外,即使无法检测到细胞因子的血浆水平,测定sE血浆水平可能有助于检测脓毒症病理状态下细胞因子诱导的内皮细胞活化。